ACPA levels exceeding 8 U/ml were found in 17.8% of arthritis patients, but not in control subjects (p = 0.095), without significant correlation to pulmonary anomalies on CXR (p = 1.000) (Tables 2, 3). Here, PRTN3 is linked to arthritic joint disease.